The Endovascular Aneurysm Repair (EVAR) Market Is Expected To Reach US$1.3 Billion by 2012 According To the Report 'Abdominal Aortic Aneurysm Endovascular Technology & Market Forecasts'.
It is estimated that approximately 4.5 million people in the developed word are living with an abdominal aortic aneurysm and each year 600,000 new cases are diagnosed.
Patients typically have no symptoms and, when they are diagnosed, they often undergo complex open surgical repair. Stent-graft therapy provides a minimally-invasive alternative, with reduced recovery times and potentially improved survival rates.
By the end of 2006 the global market for abdominal aortic aneurysm stent-grafts has reached US$610 million and has been growing at double digit rate.
Technical improvements in graft design and advancement in delivery techniques will result in the increased application of Endovascular Aneurysm Repair (EVAR) and the market is expected to reach US$1.3 billion by 2012.
Our Abdominal Aortic Aneurysm - Endovascular Technology & Market Forecast is an exclusive introduction to this rapidly growing market.
The report provides a brief, but through, analysis of this market with profiles of leading participants and forecasts to the year 2012.
With Abdominal Aortic Aneurysm - Endovascular Technology & Market Forecast, you'll be able to better:
- Identify emerging technologies and the companies behind them.
- Leverage your own technology and brain storm new business opportunities.
- Assess market size and growth potential.
- Understand current market dynamics, competitor's positions and market shares.
- Assess market potential and have access to forecasts till 2012.
- Monitor the competition's marketed and in-development products.
- Investigate mergers, acquisitions and licensing possibilities
Abdominal Aortic Aneurysm - Endovascular Technology & Market Forecast is targeted at busy senior executives in medical technology companies who are interested in developing an understanding of this emerging growth area.
Chapter Titles Include:
1. Executive Summary
2. State of the Science
3. State of the Technology
4. Companies & Products
5. Market Forecast
The Companies and Products mentioned inside report include:
- Aptus Endosystems
- Boston Scientific
- Braile Biomedica
- Cook Medical
- Edwards Lifesciences
- Gore Medical
- Lombard Medical
- Nano Endoluminal
For more information visit http://www.researchandmarkets.com/reports/c76068.
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 30, 2007|
|Previous Article:||RMA/AFS Risk Analysis Service Metrics Continue To Show Further Deterioration in Middle Market Credit Quality.|
|Next Article:||The TA Publishes Guidance for Channel Clearing Request Process.|